Elys New Logo.png
Elys BMG Group Announces Approval For Grand Central’s H Street Sportsbook in Washington, DC.
March 07, 2024 08:00 ET | Elys BMG Group, Inc.
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Elys BMG Group, Inc. (“Elys” or the “Company”) (OTC: ELYS), an interactive gaming and sports betting technology company, today announces that Grand...
BCAB.jpg
BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 07, 2024 08:00 ET | BioAtla, Inc.
Five abstracts accepted for poster presentation highlight Company’s proprietary Conditionally Active Biologic (CAB) technologyDifferentiated preclinical activity for CAB anti-Nectin4-antibody drug...
RAPT Therapeutics_Logo_Color.png
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024 08:00 ET | RAPT Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and...
isologotipo d·local_CMYK (1).jpg
dLocal to Report Fourth Quarter 2023 Financial Results
March 07, 2024 08:00 ET | DLocal Limited
MONTEVIDEO, Uruguay, March 07, 2024 (GLOBE NEWSWIRE) -- DLocal Limited (NASDAQ: DLO, “dLocal” or the “Company”), a technology-first payments platform enabling global enterprise merchants to connect...
STRATA Skin Sciences Logo.jpg
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
March 07, 2024 08:00 ET | STRATA Skin Sciences, Inc.
HORSHAM, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and...
briacell-logo-square-a.jpg
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
March 07, 2024 08:00 ET | BriaCell Therapeutics Corp.
Agreement with a leading cancer treatment group to advance the clinical development of Bria-OTS+ (breast cancer) and Bria-PROS+ (prostate cancer), BriaCell’s novel off-the-shelf personalized cancer...
spectral-ai-global-newswire.png
Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem
March 07, 2024 08:00 ET | Spectral AI, Inc.
DALLAS, March 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
Adamas1.png
Adamas One Corp. Receives Prestigious Award for Best Lab-Grown Manufacturer for 2023
March 07, 2024 08:00 ET | Adamas One Corp.
SCOTTSDALE, Ariz., March 07, 2024 (GLOBE NEWSWIRE) -- Adamas One Corp. (NASDAQ: JEWL), a leading innovator in lab-grown diamond technology, is proud to announce that it has been honored with the...
Tonix2.jpg
Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy
March 07, 2024 08:00 ET | Tonix Pharmaceuticals Holding Corp.
Data support evaluation of the effects of two weeks of TNX-102 SL therapy on severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) and PTSD after civilian motor vehicle...
illumin_logo.jpg
illumin Reports Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024 08:00 ET | illumin
Total Revenue of $37.0 million for the Fourth QuarterFull year Self-Service Revenue up 33% YoYQ4 illumin Self-Service Revenue up 75% QoQ and 271% YoY (All monetary figures are expressed in Canadian...